Alhemo, an anti-tissue factor pathway inhibitor given as a once-daily subcutaneous shot, raises levels of the bloodclotting protein thrombin
In light of the substantial in vivo and in vitro evidence supporting the efficacy of GLP-1 RAs, further research into their protective mechanisms is imperative
As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Mounjaro works by enhancing insulin secretion when blood glucose levels are elevated, suppressing glucagon release, slowing gastric emptying, and reducing appetite
The GutBrain Axis and Appetite Regulation The gastrointestinal tract communicates directly with the brain through a network known as the gutbrain axis
For many people in the UK living with thyroid conditions, weight management can feel like an uphill struggle against their own biology
Whether you're an over-the-top partier or an undercover crime fighter in a pastel suit